The Dangers of Drugs via Shutterstock, Photographer Julien Tromeur
The cycling world is collectively sighing this morning, some in relief, others in disgust. If you're like me, no matter how you feel about the two big doping stories jamming the cycling airwaves today, the prevailing emotion is simple, overwhelming fatigue.
After literally years of waiting, in the past 72 hours the cycling world received decisions in not one, but two of the highest profile doping inquests running. Last Friday, the U.S. Attorney for the Central District of California announced in a short statement that the nearly-two-year investigation into whether Lance Armstrong used performance-enhancing drugs was closed and that no charges will be filed. Then this morning, the Court for Arbitration for Sport handed Alberto Contador a two-year ban for his positive test for Clenbuterol at the 2010 Tour de France. Contador's ban will be served retroactively, and the Spaniard will lose all results since the doping infraction, including the 2010 Tour de France title.
Though contrasting in many ways, the two decisions offer similar lessons.